Our Features
RCEVI offers a range of customized services, such as antiviral testing, validation of diagnosis, and vaccine/drug development. We have launched various productions in Taiwan via out-licensing agreements and collaborate with research centers at Chang Gung University for high-quality research and development, emphasizing their core competencies in all the tests of viruses.
Services
virus detection, virus isolation, antiviral or vaccine efficacy evaluation, high-throughput antiviral screening, etc.
In vitro platform
plaque assay, plague reduction assay, neutralization assay, hemagglutination inhibition (HI) assay, RT-qPCR, ELISA, cytotoxicity, etc.
In vivo platform
mouse model for virus challenge/ antiviral screening, in vivo imaging system (IVIS), etc.
Pathogens
Respiratory viruses: Coronavirus, Influenza virus, Respiratory Syncytial virus, Parainfluenza viruses, etc.
Enteroviruses: Enterovirus-A71, Enterovirus-D68, Coxsackievirus, etc.
Arbovirus: Dengue virus, ZIKA virus, etc.
Enteric virus: Norovirus, Rotavirus, etc.
Facilities
Biosafety Level 2
Animal Biosafety Level 2
Biosafety Level 3
Animal Biosafety Level 3
Customize
We understand that each customer has unique needs, so we offer a customize service contact for further discussion. You can discuss what you need with our team of professionals and they will provide you with the best solution. Get in touch with us today and let us help you achieve your goals.
Welcome to RCEVI, the leading provider of biotechnological services. Let us help you with anything you need, from building the perfect solutions to advancing your research. Our team is highly qualified and experienced, dedicated to helping you reach your maximum potential.